Nikolai I. Tankovich
President chez Stemedica Cell Technologies, Inc.
Profil
Nikolai I.
Tankovich is currently the Director at Biopharma Scientific, Inc. and the President, Director & Chief Medical Officer at Stemedica Cell Technologies, Inc. He holds a doctorate degree from Moscow State University Lomonosov and Semashco Medical University, and a graduate degree from Moscow University.
Postes actifs de Nikolai I. Tankovich
| Sociétés | Poste | Début |
|---|---|---|
Biopharma Scientific, Inc.
 Biopharma Scientific, Inc. Pharmaceuticals: MajorHealth Technology Biopharma Scientific, Inc. develops and manufactures pharmaceuticals. It provides new frontier of nutrition through nanotechnology delivery systems, innovations in bio-active extraction processes and advanced formulation methodologies. The company was founded by John H. Maher and Bruce L. Howe in 2004 and is headquartered in San Diego, CA | Directeur/Membre du Conseil | - |
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | President | - |
Formation de Nikolai I. Tankovich
| Moscow State University Lomonosov | Doctorate Degree |
| Moscow University | Graduate Degree |
| Semashco Medical University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Biopharma Scientific, Inc.
Biopharma Scientific, Inc. Pharmaceuticals: MajorHealth Technology Biopharma Scientific, Inc. develops and manufactures pharmaceuticals. It provides new frontier of nutrition through nanotechnology delivery systems, innovations in bio-active extraction processes and advanced formulation methodologies. The company was founded by John H. Maher and Bruce L. Howe in 2004 and is headquartered in San Diego, CA | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Health Technology |
